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Abstract
Calcium-calmodulin-dependent protein kinase IV (CaMKIV) phosphorylates the major
transcription factor cyclic AMP-response element binding protein (CREB), which plays a role in
emotional behavior. Here, CaMKIV knockout mice (CaMKIV-/-) were tested in a battery of stress
and anxiety-related behavioral tests, to determine if CaMKIV plays a role in emotional behavior.
CaMKIV-/-exhibited a decrease in anxiety-like behavior in both the elevated plus maze and dark-light
emergence tests when compared to wild-type mice. Both the acoustic startle response and
prepulse inhibition of startle were decreased with the deletion of CaMKIV. In addition, CaMKIV-/-
mice displayed a lack of stress-induced analgesia following restraint or cold swim stress. Our results
demonstrate a key role for CaMKIV in anxiety and stress-related behavior.
Introduction
Calcium-calmodulin-dependent protein kinase IV (CaM-
KIV) plays a role in the activity-dependent phosphoryla-
tion of cyclic AMP-responsive element binding protein
(CREB) and CRE modulator (CREM), which regulate the
expression of genes involved in neuroplasticity [1], learn-
ing and memory [2-4], emotional behavior [5-7] and
molecular changes induced by antidepressants [8]. Several
protein kinase cascades regulate CREB function in the
CNS [1,9], these include the cAMP signaling pathway and
the Ca2+-calmodulin dependent protein kinase pathway.
Among different Ca2+-dependent protein kinases, CaM-
KIV is detected predominantly in the nuclei of neurons
[10,11], therefore CaMKIV may play a unique role in the
phosphorylation of CREB and in the regulation of neuro-
nal gene expression [12].
CaMKIV is normally expressed in the amygdala and hip-
pocampus, two brain structures involved in the regulation
of anxiety and CaMKIV deficient mice exhibit defects in
contextual and auditory fear memory [13]. A recent study
reported that the CaMKIV signaling pathway may play a
role in the excitation-mediated regulation of neuropep-
tides involved in the pathophysiology of anxiety in vitro
[14]. However, molecular and physiological roles of CaM-
KIV in emotional behavior have yet to be investigated.
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Previous studies have implicated that both CREB [5] and
CREM [6] are activated by CaMKIV and both have been
shown to play a role in emotional behavior. In the present
study we wanted to determine if the deletion of CaMKIV
would result in changes in anxiety and stress-related
behaviors. Here we report that CaMKIV-/- mice exhibit
decreased anxiety-like behaviors in several anxiety para-
digms and develop less stress-induced analgesia. Our
results demonstrate a key role for CaMKIV in mediating
changes in anxiety and stress-related behaviors.
Materials and methods
Subjects
All subjects were 8–12 weeks old male mice. The CaMKIV-
/- mice were derived as described [15] and bred for several
generations on the C57BL/6 background (F12–F16).
While wild-type littermates were used in some experi-
ments, C57BL/6 mice were purchased from Charles River
to use as controls in others. We do not feel that this repre-
sents a problem with the genetics background since the
CaMKIV transgenic line can be considered congenic with
C57BL/6 and preliminary results showed that there was
no difference in the behavior of wild-type littermates from
C57BL/6 mice. Mice were housed on a 12-h light-dark
schedule with food and water available ad libitum. All
experiments were carried out in accordance with the rules
and regulations of the Animal Care and Use Committee at
the University of Toronto. All efforts were made to mini-
mize the animal's suffering and to reduce the number of
animals used. No visual difference between C57BL/6 and
CaMKIV-/- mice was noticeable and experiments were per-
formed blind when possible.
Elevated plus-maze test
The elevated plus maze (Med Associates, St Albans, Vt)
consists of two open arms and two closed arms situated
opposite each other and separated by a 6 cm square center
platform. Each runway is 6 cm wide and 35 cm long. The
open arms have lips that are 0.5 cm high and the closed
arms are surrounded on three sides by 20 cm walls. The
floors and walls are black polypropylene. For each test, the
animal was placed in the center square and allowed to
move freely for five minutes. Open arm entries were
defined as the mouse having all four paws onto the open
arm. The number of entries and time spent in each arm
was recorded.
Light/Dark box
The testing apparatus consisted of a rectangular Plexiglas
box (44 × 8.5 × 25 cm) equally divided into a light, open
topped, compartment connected by a door (17 cm in
height) to a dark, closed topped, opaque compartment.
Each mouse was placed in the light box and was allowed
10 sec to explore before the door to the dark box was
opened. Each animal was tested for 10 min. The time
spent in the light compartment and the number of light/
dark transitions were recorded.
Dark-light emergence Task
The apparatus consisted of a black opaque plastic box (13
× 11 × 8.5 cm) with a small opening (3 × 6 cm) placed
along one side of the open field evenly illuminated by
white overhead lighting. The exit was faced out into the
open field. Mice were individually placed into the box
with the exit blocked for a 5 min habituation period. At
the end of the habituation period, the exit was opened
and the mice were allowed to freely explore the open field
for 5 min. The latency to emerge from the box, time out of
the box, time spent assessing the open field (scanning the
open field with the head but less than four paws out of the
box) and box/open field transitions were recorded.
Acoustic startle and prepulse inhibition (PPI)
Testing was conducted in a startle chamber from Med
Associates (Med Associates Inc., St. Albans, VT). The star-
tle chamber consists of a nonrestrictive Plexiglas cylinder
(4.4 cm) in diameter, resting on a platform in a ventilated
and sound attenuating chamber. A high-frequency
speaker mounted behind the cylinder produced all the
acoustic and prepulse stimuli. Mouse movements were
detected and transduced by a stablimeter mounted under
the cylinder and digitized and stored by a computer and
interface assembly. Startling stimulus began at 80 dB and
1 ms readings were recorded to obtain the amplitude of
the animal's startle or prepulse response to each stimulus.
For acoustic startle, mice were acclimated in the chamber
for 20 min and 80 trials of 80, 85, 90, 95, 100, 110 and
120 dB noise bursts were presented over a 45-min test ses-
sion. The inter-trial interval varied randomly from 10 to
20 s, with an average of 15 s. For PPI, each test session
consisted of 55 trials and was initiated with a 10-min
acclimation period. Testing began after the initial explor-
atory behavior had diminished. Three different trial types
were presented at random: 20 ms prepulse of 80, 90 or
100 dB, 100 ms before a startle noise burst (112 dB), star-
tle noise burst (112 dB) alone and background noise
alone. For both acoustic startle and PPI the background
noise was at 70 dB.
Stress induced nociceptive tests
To induce stress, mice were forced to swim in water
(10°C) for 3 min or were restrained for 30 min. Animals
were individually restrained in small cylindrical tubes
with a diameter slightly larger than a mouse's body.
Responses to the hot-plate and tail-flick were measured at
different time points up to 60 min after stress. Data are
presented as the mean response latency (s) or maximum
possible inhibition (MPI = (response latency – baseline
response latency)/ (cut-off time – baseline responseMolecular Pain 2005, 1:22 http://www.molecularpain.com/content/1/1/22
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latency) × 100). The total effect of stress over time, the
area under the curve (MPI versus time) was used.
GeneChip analysis
Total RNA was isolated from the forebrains of two C57BL/
6 or CaMKIV-/- mice using TRIzol reagent (Invitrogen,
Carlsbad, CA, USA) and purified with RNeasy mini kit
(Qiagen). RNA quality was checked visually on an agarose
gel and also by Agilent BioAnalyzer. Combined RNA was
subjected to gene chip analysis (Affymetrix Mouse 430
2.0). First-strand synthesis, fragmentation, hybridization
and washing were done according to GeneChip (Affyme-
trix Inc.) protocol. The array was scanned, and informa-
tion was extracted using the GeneChip Expression
Analysis program (Affymetrix) and analyzed using the
GeneChip Operating System (GCOS, Affymetrix).
Reverse transcription-PCR analysis
First strand-cDNAs were synthesized from total RNA iso-
lated from the forebrains of C57BL/6 and CaMKIV-/- mice
previously extracted for the GeneChip experiment (n = 2
for C57BL/6 and CaMKIV-/- mice) using SuperScript III RT
(Invitrogen) with oligo(dT) as a primer. The primers for
RT-PCR were as follows: Oxytocin: sense, 5'-TTGCTGCCT-
GCTTGGCTTAC-3', antisense, 5'-TATTCCCAGAAAGT-
GGGCTC-3', arginine vasopressin: sense, 5'-
ACACTACGCTCTCCGCTTGT-3', antisense, 5'- GGGCAG-
GTAGTTCTCCTCCT-3', Transthyretin: sense, 5'- ATGGT-
CAAAGTCCTGGATGC-3', antisense, 5'-
CAGAGTCGTTGGCTGTGAAA-3', connexin 43: sense, 5'-
GGACTGCTTCCTCTCACGTC-3', antisense, 5'- CAGCTT-
GTACCCAGGAGGAG-3' and synaptotagmin 1: sense 5'-
CAATACTGCCATTCCCTCGT-3', antisense, 5'- GTAG-
CAGGCTCACCTTCCTG-3'. Glyceraldehyde-3-phosphate
dehydrogenase (GAPDH) was ampli?ed as an internal
control by using the primer sets: sense, 5-AACGACCCCT-
TCATTGAC-3' antisense 5'-TCCACGACATACTCAGCAC-
3'. PCR conditions were adjusted to be in a linear range of
amplification.
Data analysis and Statistics
Results were analyzed by t-test, paired t-test, ONE-WAY
ANOVA, TWO-WAY ANOVA followed by post-hoc Stu-
dent-Newman-Keuls test to identify significant differ-
ences. All data are expressed as mean ± S.E.M. In all cases,
P < 0.05 was considered statistically significant.
Results
Decreased anxiety-related behaviors in CaMKIV-/- mice
To determine if CaMKIV plays a role in the expression of
anxiety-like behaviors, CaMKIV-/- mice were tested in the
elevated plus-maze, dark-light emergence test, light/dark
box, acoustic startle and for the prepulse inhibition of
startle. Previous studies showed that general locomotor
activity was similar between CaMKIV-/- mice in an open
field when compared to wild-type mice, however, CaM-
KIV-/- mice spent significantly more time exploring the
center of the open field, which is indicative of a reduction
in anxiety-like behavior [16]. To further assess anxious
behaviors in CaMKIV-/- mice, we used the elevated plus
maze, which is a well-validated, conventional test for anx-
iety-related behavior in mice [17]. In this test, an increase
in anxiety correlates with a decrease in exploration of the
open arms of the maze. The number of entries into the
closed arms or the total number of arm entries can be
taken as a measure of locomotor activity. CaMKIV-/- mice
spent significantly more time in the open arms of the
plus-maze (Fig. 1b; P < 0.001) and displayed an increase
in the number of open arm visits (Fig. 1a; P < 0.01) when
compared to wild-type mice. The number of entries into
the closed arms (Fig. 1c; P < 0.05) and the total number of
arm entries was also significantly increased (Fig. 1d; P <
0.001), suggesting an increase in locomotor activity.
Increased exploration in the dark-light emergence test
To strengthen our hypothesis that CaMKIV may play a
role in the regulation of anxiety-like behaviors, we tested
the performance of CaMKIV-/- mice in the dark-light emer-
gence test [18]. CaMKIV-/- mice again displayed a signifi-
cant decrease in anxiety-like behavior. We found that the
overall time spent in the open field was significantly
greater in CaMKIV-/- mice (Fig. 2a; P < 0.05). We further
examined changes in anxiety-related behavior using the
light/dark box [19]. Anxiogenic agents decrease, while
anxiolytic drugs increase the amount of time spent in the
light half of the chamber [20]. The total time spent in the
light compartment did not significantly differ between
wild-type and CaMKIV-/- mice (Fig. 2b). However, CaM-
KIV-/- mice displayed a significant decrease in the number
of light/dark transitions (Fig 2c; P < 0.05). Since this test
is based on a mouse's natural aversion to brightly lit
spaces, an overall decrease in exploration by CaMKIV-/-
mice may represent a reduction in conflict between the
two chambers. Although CaMKIV-/- mice did not display a
consistent anxiety-like phenotype in the light/dark box
paradigm, evidence suggests that similar rodent behavio-
ral tests may measure different forms of anxiety-like
behavior [21,22]. Previous studies have found targeted
gene mutations can produce anxiety-like phenotypes in
some tests but not others [22,23]. Therefore, the decrease
in anxiety-like behavior seen in the elevated plus-maze
and dark-light emergence test is likely to reliably represent
the anxiety phenotype in CaMKIV-/- mice.
Impaired startle and prepulse inhibition of startle
The acoustic startle response is elicited by a sudden loud
acoustic stimulus and is characterized by a coordinated
contraction of the muscles of the neck and extremities.
The percent prepulse inhibition (PPI) is an index of sen-
sorimotor gating. We examined the acoustic startleMolecular Pain 2005, 1:22 http://www.molecularpain.com/content/1/1/22
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response and PPI in mice lacking CaMKIV. Consistent
with a reduction in anxiety-like behaviors, CaMKIV-/- mice
displayed a decrease in baseline acoustic startle ampli-
tudes (Fig. 3a; P < 0.05, P < 0.001, and P < 0.001 for 100
dB, 110 dB and 120 dB respectively). Similarly, CaMKIV-/
- mice showed a significant reduction in prepulse inhibi-
tion of the startle reflex at prepulse intensities of 90 and
100 dB (Fig 3b; P < 0.001 for both intensities). These
results further support our hypothesis that CaMKIV may
play a role in emotional behaviors.
CaMKIV plays a role in stress-induced analgesia
To determine if CaMKIV plays a role in stress-induced
behavioral changes, CaMKIV-/- and wild-type mice were
tested for stress-induced analgesia after either restraint or
swim stress. Consistent with previous studies [24],
restraint stress induced analgesic effects in the tail-flick
and hotplate tests in wild-type mice (Fig. 4a–d). In con-
trast, CaMKIV-/- mice failed to show any analgesia in both
tests (P < 0.01 for both tests and area under the curve P <
0.001 and P < 0.05 for hotplate and tail-flick tests respec-
tively). We can exclude the possibility that this is due to
altered spinal nociceptive transmission since CaMKIV-/-
mice have unaltered baseline tail-flick and hotplate
responses [13]. Similar results were obtained using the
cold-swim stress test (Fig. 4e–f; P < 0.05 comparisons of
CaMKIV-/- and wild-type mice using area under the curve).
Here, we measured behavioral nociceptive responses on
the hot-plate after animals were forced to swim in cold
water.  CaMKIV-/-  mice exhibited significantly reduced
stress-induced analgesia when compared to wild-type
controls. Taken together, these results suggest a role for
CaMKIV in the regulation of stress-induced analgesia.
Changes in Stress/anxiety-related gene expression
Several studies show that altering CREB function can
change anxiety-like behaviors [7,25] and since CaMKIV
Decreased anxiety-like behavior in CaMKIV-/- mice Figure 1
Decreased anxiety-like behavior in CaMKIV-/- mice. a, CaM-
KIV-/- mice (n = 14 mice) displayed a significantly increased 
number of open arm entries (t(27) = -3.89, P < 0.001) com-
pared with wild-type mice (n = 19 mice) in the elevated plus-
maze. b, The percentage of time spent by CaMKIV-/- mice in 
the open arms was significantly greater than wild-type mice 
(n = 19 mice, t(31) = -3.96, P < 0.01). c, d, There was a sig-
nificant increase in the number of closed arm entries in CaM-
KIV-/- mice (n = 14 mice, t(27) = -2.21, P < 0.05) as well as 
total arm entries (n = 14 mice, t(27) = -3.90, P < 0.001) when 
compared to wild-type mice (n = 19 mice).
Dark-light emergence test and Light/Dark box paradigm Figure 2
Dark-light emergence test and Light/Dark box paradigm. a, 
In the dark-light emergence test, CaMKIV-/- mice (n = 7 mice) 
spent significantly more time outside the chamber compared 
to wild-type mice (n = 8 mice, t(13) = -2.65, P < 0.05,). b, In 
the light/dark box, no difference was seen between CaMKIV-/- 
and wild-type mice in the time spent in the light compart-
ment. c, However, wild-type mice (n = 10 mice) displayed an 
increase in the number of light/dark transitions compared 
with CaMKIV-/- mice (n = 6, t(14) = 2.44, P < 0.05).Molecular Pain 2005, 1:22 http://www.molecularpain.com/content/1/1/22
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can directly modulate the activity of this major transcrip-
tion factor, GeneChip analysis was performed on the fore-
brain of CaMKIV-/- mice to uncover any changes in the
expression levels of genes related to emotional behavior.
We compared gene expression profiles between CaMKIV-/
- and wild-type mice and found 233 genes to be differen-
tially expressed with lower expression levels in CaMKIV-/-
mice than in wild-type animals. We filtered out the top
five anxiety/stress-related genes among down-regulated
genes based on previous literature (Table 1). Of particular
interest, we found that the expression level of the neu-
ropeptide oxytocin, which is known to mediate emotional
behaviors such as social recognition [26], aggression [27]
and stress-induced analgesia [24], was decreased in CaM-
KIV-/- mice by more than twofold (2.83 fold, P < 0.05). To
confirm this GeneChip data, reverse transcription-
polymerase chain reaction (RT-PCR) was performed to
measure the mRNA expression level of oxytocin in CaM-
KIV-/- mice (Fig. 5). The results of the RT-PCR were consist-
ent with those from GeneChip analysis, showing a
decrease in oxytocin mRNA in CaMKIV-/-. This suggests
that, as an upstream regulator of CREB, CaMKIV may play
a role in the regulation of anxiety-related genes such as
oxytocin. Since oxytocin has been shown to mediate
stress-induced analgesia in mice [24] and our gene expres-
sion analysis showed that the basal expression of oxytocin
is reduced after the deletion of CaMKIV, this result is con-
sistent with the lack of stress induced analgesia in CaM-
KIV-/- mice.
Discussion
In the present study, we show that the genetic disruption
of CaMKIV in mice results in a decrease in anxiety-like
behavior and the abolishment of stress-induced analgesia.
CaMKIV-/- mice display reduced anxiety-like behaviors in
the elevated plus-maze, dark-light emergence test, and in
the acoustic startle reflex and PPI. Furthermore, these mice
lack stress-induced analgesia induced by forced swim or
restraint stress.
Several kinase cascades regulate CREB function in the CNS
[1,9], these include the cAMP signaling pathway and Ca2+-
calmodulin-dependent protein kinase pathway. The
nuclear location of CaMKIV, its ability to phosphorylate
CREB and its broad expression throughout forebrains
areas suggests that CaMKIV may play an important role in
higher brain function. CaMKIV may also play a role in
CREB phosphorylation by modulating other kinase path-
ways. Studies in cell culture systems demonstrated the reg-
ulatory role of CaMKIV in MAP kinase and cAMP
pathways [28,29]. Disturbances in any of these pathways
could potentially disrupt the control of CREB-mediated
anxiety-related gene expression. Recent data showed the
involvement of the CaMKIV cascade in antidepressant
mechanisms [30]. In-vitro experiments have suggested a
role for the CaMKIV signaling pathway in the excitation-
mediated regulation of corticotrophin-releasing hormone
(CRH) synthesis [14].
Previous studies of CREB mutant mice reported an
increase in anxiety-like behavior in several behavioral
paradigms including the elevated plus-maze, black and
white box and open field [5]. Although mice lacking dif-
ferent isoforms of CREB responded differently to certain
stressful situations, all CREB mutants displayed anxiety-
like responses in all behavior models [7,25]. In another
study, the CREB-related transcription factor CREM was
shown to be involved in the control of anxiety-like behav-
ior. CREM mutant mice were hyperactive in the open field
but displayed reduced anxiety-like behaviors in the ele-
vated plus-maze and zero maze [6]. From our data, CaM-
KIV-/- mice displayed reduced anxiety-like behavior by
spending more time in the open arms of the elevated plus-
maze, which correlates with the phenotype of the CREM
Decreased acoustic startle and PPI Figure 3
Decreased acoustic startle and PPI. a, Baseline startle ampli-
tudes were significantly decreased at 100, 110 and 120 dB in 
CaMKIV-/- mice (wild-type mice, n = 7 mice, CaMKIV-/- n = 13 
mice, at intensities of 100, 110, 120 dB, q = 3.44, P < 0.05, q 
= 5.02, P < 0.001, q = 6.55, P < 0.001 respectively). b, Pre-
pulse inhibition of the startle reflex was significantly 
decreased at prepulse intensities of 90 and 100 dB (wild-type, 
n = 10 mice, CaMKIV-/-, n = 18 mice, at intensities of 90 dB, q 
= 3.98, P < 0.01, 100 dB, q = 4.05, P < 0.01).Molecular Pain 2005, 1:22 http://www.molecularpain.com/content/1/1/22
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mutant mice. However, mice lacking CaMKIV did not
show hyperlocomotor activities in the open field [15].
Our results show that CaMKIV-/- mice made significantly
more entries into the open and closed arms of the elevated
plus-maze, suggesting an increase in locomotor activity.
One explanation for this discrepancy may be because
CaMKIV-/- mice have less anxiety so they may spend more
time exploring the anxious environment of the elevated
Restraint and cold swim stress Figure 4
Restraint and cold swim stress. a, c, Antinociceptive responses in the hot-plate (n = 8 wild-type mice, n = 9 CaMKIV-/- mice, 
F(1,7) = 68.21, P < 0.01) and tail-flick test (F(1,7) = 13.59, P < 0.01) following restraint stress (30 min) was significantly 
decreased in CaMKIV-/- mice. b, d, antinociceptive effect presented as area under the curve between 0 to 60 min after restraint 
stress in the hot-plate test (t(15) = 4.13, P < 0.001) and tail-flick test (t(15) = 2.86, P < 0.05) show a lack of stress-induced anal-
gesia in CaMKIV-/- mice. e, f, Similarly, hotplate responses after cold-swim test (n = 11 wild-type mice, n = 12 CaMKIV-/- mice) 
was significantly reduced in CaMKIV-/- mice (F(1,6) = 7.39, P < 0.05, area under the curve, t(21) = 2.26, P < 0.05)Molecular Pain 2005, 1:22 http://www.molecularpain.com/content/1/1/22
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plus maze when compared to wild-type mice. These
results suggest that CaMKIV-/- mice have a decrease in anx-
iety in the plus-maze compared to wild-type mice, and
hint that CaMKIV may play a role in regulating levels of
anxiety. Therefore, the contrasting phenotypes of between
CaMKIV, CREB and CREM knockout mice emphasize the
complexity of the transcription factor and genetics under-
lying such emotional behavior. These studies further sug-
gest that CaMKIV may play an important role in anxiety-
like behavior through its regulation of CREB since CREB
mutant mice displayed alterations in emotional behavior
[5,7,25].
Microarray analysis provides us the opportunity to screen
for changes in thousands of genes at the same time [31]
and this technology was applied to several studies of gene
expression ranging from complex clinical diseases such as
schizophrenia [32,33] to human cancer [34]. We used
microarray analysis to assay the relative gene expression
levels in the forebrain of CaMKIV-/- and wild-type mice.
We found at least 200 genes down-regulated, five of which
were stress/anxiety-related genes (Table 1). Of these
genes, two were neuroendocrine hormones; vasopressin
and oxytocin. Mice lacking the vasopressin VIa receptor
exhibit markedly reduced anxiety-like behavior [35] while
mice lacking oxytocin display elevated anxiety-like behav-
ior [36,37] and lack stress-induced analgesia [24]. Inter-
estingly, other genes found to be reduced in CaMKIV-/-
mice include the intracellular transportor gene,
transthyretin; secretory vesicle protein, synaptotagmin 1,
and a gap junction protein, connexin 43. The down-regu-
lation of these genes suggests that the deletion of CaMKIV
may affect the expression of genes involved in the regula-
tion of presynaptic terminals and its structure. These genes
are shown to be anxiety/stress related and may have other
roles in addition to anxiety. The GeneChip data included
in this study may help us to find a mechanism for the role
of CaMKIV in anxiety and such a mechanism may include
oxytocin.
Of interest, accumulating evidence suggests that oxytocin
possesses anxiolytic properties and is important for stress-
induced analgesia [37-39]. Oxytocin in the amygdala is
essential for social recognition and the control of anxiety
[26,36,40] and central administration of oxytocin is anxi-
olytic and attenuates the stress response. CaMKIV-/- mice,
with reduced oxytocin levels, display a lack of stress-
induced analgesia. Contrary to observations in oxytocin
deficient mice [37-39], which displayed heightened anxi-
ety behaviors, the present data showed that CaMKIV-/-
mice display lower anxiety-like behaviors. Our findings
imply that changes in oxytocin expression may contribute
to the changes in anxiety level of CaMKIV-/- mice. Thus, it
appears that CaMKIV may regulate the expression of many
anxiety-related genes, including oxytocin, but that this
regulation cannot solely account for the behavioral phe-
notype. While future studies are needed to thoroughly
characterize changes in gene expression that result from
the deletion of CaMKIV and how these changes affect
behavioral phenotypes, our initial GeneChip data pro-
vides a good starting point for the dissection of molecular
changes responsible for the anxiety phenotype of CaM-
KIV-/- mice.
Our results suggest that a nuclear protein kinase, with
broad forebrain distribution and the ability to affect gene
expression through the activation of CREB, plays a role in
anxiety-like behavior and that modulation of CaMKIV
activity may prove useful in modifying anxious behavior.
Table 1: Top 5 down-regulated anxiety-related gene expression in CaMKIV deficient mice
Probe Gene name Accession Symbol LocusLink Gene Description
1450794_at Arginine vasopressin NM_009732.1 Avp 11998 neurohypophysial peptide[35]
1420556_at Oxytocin NM_011025.1 Oxt 18429 neurohypophysial peptide[37]
1451580_a_at Transthyretin BC024702.1 Ttr 22139 transporter of thyroxine and vitamin A[41]
1415801_at Connexin 43 M63801.1 14609 subunit of gap junction channel[42]
1421990_a Synaptotagmin 1 NM_009306.1 Syt1 20979 Ca2+ sensor for transmitter release[43]
Decreased oxytocin mRNA expression in CaMKIV-/- mice Figure 5
Decreased oxytocin mRNA expression in CaMKIV-/- mice. 
RT-PCR analysis revealed that the mRNA level of oxytocin 
was decreased in CaMKIV-/- compared with wild-type mice. 
RT-PCR analysis confirmed the altered expression of oxy-
tocin identified from GeneChip analysis.Molecular Pain 2005, 1:22 http://www.molecularpain.com/content/1/1/22
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Future studies are needed to elucidate the role of CaMKIV
in the molecular changes involved in the modulation of
anxiety-like behaviors.
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